First Time Loading...
G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 830.05 INR 1.07% Market Closed
Updated: May 16, 2024

Balance Sheet

Balance Sheet Decomposition
Glenmark Life Sciences Ltd

Current Assets 19.2B
Cash & Short-Term Investments 3.9B
Receivables 7.7B
Other Current Assets 7.6B
Non-Current Assets 9.3B
Long-Term Investments 111.1m
PP&E 9B
Intangibles 148.5m
Other Non-Current Assets 122.6m
Current Liabilities 4.4B
Accounts Payable 3.7B
Accrued Liabilities 120.3m
Other Current Liabilities 580.8m
Non-Current Liabilities 793.2m
Long-Term Debt 147.6m
Other Non-Current Liabilities 645.6m

Balance Sheet
Glenmark Life Sciences Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
21
100
1 156
5 122
2 838
Cash
0
1
1
221
558
Cash Equivalents
20
99
1 155
4 901
2 281
Total Receivables
5 176
7 073
7 268
7 152
9 189
Accounts Receivables
4 481
6 386
6 195
6 735
8 068
Other Receivables
695
687
1 073
417
1 122
Inventory
4 008
4 128
5 134
5 162
6 042
Other Current Assets
102
300
432
210
434
Total Current Assets
9 307
11 601
13 990
17 646
18 503
PP&E Net
5 303
5 498
5 790
6 763
8 242
PP&E Gross
5 303
5 498
5 790
6 763
8 242
Accumulated Depreciation
187
475
773
1 130
1 516
Intangible Assets
64
72
79
104
180
Note Receivable
0
0
12
0
0
Long-Term Investments
1
1
86
56
83
Other Long-Term Assets
79
84
14
141
13
Total Assets
14 754
N/A
17 256
+17%
19 971
+16%
24 710
+24%
27 021
+9%
Liabilities
Accounts Payable
1 874
2 035
2 226
3 244
4 095
Accrued Liabilities
96
121
204
421
551
Short-Term Debt
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
17
23
Other Current Liabilities
11 834
10 919
9 784
159
376
Total Current Liabilities
13 804
13 075
12 214
3 840
5 044
Long-Term Debt
0
0
0
12
171
Deferred Income Tax
69
164
229
315
424
Total Liabilities
13 873
N/A
13 239
-5%
12 443
-6%
4 167
-67%
5 639
+35%
Equity
Common Stock
20
20
20
245
245
Retained Earnings
862
3 997
7 508
10 249
11 087
Additional Paid In Capital
0
0
0
10 050
10 050
Total Equity
881
N/A
4 017
+356%
7 527
+87%
20 543
+173%
21 382
+4%
Total Liabilities & Equity
14 754
N/A
17 256
+17%
19 971
+16%
24 710
+24%
27 021
+9%
Shares Outstanding
Common Shares Outstanding
123
123
123
123
123

See Also

Discover More